https://www.selleckchem.com/pr....oducts/ly2090314.htm
Based on our meta-analysis across the four datasets, 10 innate and adaptive immune cell types associated with disease relapse of which 2 were internally validated using multiplex immunofluorescence. Moreover, immune cell type infiltration was a better predictors of disease relapse than Consensus Molecular Subtype (CMS) and other expression-based biomarkers (Immune-AICMCC238.1-238.9; CMS-AICMCC 241.. These data suggest that transcriptome-derived immune profiles are prognostic indicators of CRC relapse and quantification of both innat
Like
Comment
Share
